24th January 2022

$2.8m MRFF boost for vital cancer immunotherapy research

Mater Research will begin trialing a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8m grant

Latest News

22 October 2020

Genomic treasure trove

Dr Mark Adams is uncovering potential new treatments and diagnostics as he delves into the human genome.
More about Genomic treasure trove
14 October 2020

New medtech manufacturing capability

TRI launches its new state-of-the-art clinical cleanroom manufacturing and training facility, T3 Cleanrooms.
More about New medtech manufacturing capability
15 September 2020

Research focus on rare lymphomas

Haematologist, Dr Colm Keane, has a clear focus on improving patient outcomes through his lymphoma research program at TRI.
More about Research focus on rare lymphomas
14 September 2020

Drug doesn't reduce heart disease in kidney patients

TRI researchers were part of a large study looking at a commonly prescribed drug for kidney patients.
More about Drug doesn't reduce heart disease in kidney patients
10 September 2020

Invention driving needle-free vaccine delivery

TRI unpacks the Vaxxas journey as their needle-free vaccine delivery product nears commercial reality.
More about Invention driving needle-free vaccine delivery

Pages

Events

21 March 2022 9:30 AM6:00 PM

ASSC Genetics Summit 21 March 2022

The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit
More about ASSC Genetics Summit 21 March 2022

Upcoming Events

Sorry, no results found

Please try again with less restrictive search criteria